XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development (includes related party amounts of $249, $417, $752 and $776, respectively) $ 30,629 $ 49,750 $ 92,181 $ 133,747
General and administrative 7,923 8,201 23,851 23,901
Total operating expenses 38,552 57,951 116,032 157,648
Loss from operations (38,552) (57,951) (116,032) (157,648)
Other (income) expense:        
Interest income (3,350) (3,932) (10,360) (11,453)
Other expense 47 8 99 14
Total other (income) expense (3,303) (3,924) (10,261) (11,439)
Net loss (35,249) (54,027) (105,771) (146,209)
Unrealized gain on marketable securities 922 192 741 544
Foreign currency translation 199 11 182 72
Comprehensive loss $ (34,128) $ (53,824) $ (104,848) $ (145,593)
Net loss per share, basic $ (0.5) $ (0.92) $ (1.56) $ (2.51)
Net loss per share, diluted $ (0.5) $ (0.92) $ (1.56) $ (2.51)
Weighted average common shares outstanding, basic 70,667,570 58,880,427 67,694,970 58,363,174
Weighted average common shares outstanding, diluted 70,667,570 58,880,427 67,694,970 58,363,174